[Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020] [0.03%]
2020年2月27日至4月30日墨西哥新型冠状病毒肺炎流行病学特点分析
V Suárez,M Suarez Quezada,S Oros Ruiz et al.
V Suárez et al.
Background: The first case of COVID-19 detected in Mexico was on the 27th of February 2020. On the 30th of April, 64 days after this first diagnosis, the number of patients had increased exponentially, reaching 19 224 con...
A Franco-Moreno,N Muñoz-Rivas,B Mestre-Gómez et al.
A Franco-Moreno et al.
[Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?] [0.03%]
[针对“伊维菌素对新冠肺炎的作用。无知论证？”一文的回复]
M L López Reboiro,C Sardiña González,J López Castro
M L López Reboiro
Y Carlosama-Rosero
Y Carlosama-Rosero
[CoronARTvirus] [0.03%]
“冠艺术病毒”
J I Pérez Calvo,J L Ibáñez Sáenz
J I Pérez Calvo
J García-Alegría,R Gómez-Huelgas
J García-Alegría
M Esquerda,J Teres
M Esquerda
[Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic] [0.03%]
[有关心血管结局试验中肠促胰素类药物增加呼吸系统感染和急性呼吸窘迫综合征风险的meta分析：对COVID-19大流行病的启示]
D Patoulias,A Boulmpou,K Imprialos et al.
D Patoulias et al.
Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefi...
[Telemedicine, ethics, and law in times of COVID-19. A look towards the future] [0.03%]
[新冠肺炎时期的远程医疗、伦理与法律。展望未来]
C Gil Membrado,V Barrios,J Cosín-Sales et al.
C Gil Membrado et al.
The health emergency in Spain caused by COVID-19 was of such a magnitude that on March 14, 2020, a state of alarm was declared that lasted for more than three months. This ongoing pandemic has affected a vast number of people. Among the mea...
[Caution with the use of dexamethasone in patients with COVID-19 in its initial phases] [0.03%]
警惕地塞米松在新冠初期使用中的问题
J L Callejas Rubio,I Aomar Millan,M Moreno-Higueras et al.
J L Callejas Rubio et al.
Introduction: The effect of dexamethasone in the initial phase of infection by SARS-CoV-2 and its influence on COVID-19 is not well defined. We describe clinical-radiological characteristics, the cytokine storm parameters...